Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system

Pediatric Nephrology

Volumn 20, Issue 3 SPEC. ISS., 2005, Pages 295-302

  Woelfle, Joachim ^a   Chia, Dennis J ^a,b   Massart Schlesinger, Mylynda B ^a   Moyano, Paula ^a   Rotwein, Peter ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Aging; Cancer; Gene transcription; Growth regulation; Stat5

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN C; STAT5B PROTEIN;

AGING; BREAST CARCINOGENESIS; CANCER RISK; COLORECTAL CANCER; GENE CONTROL; GENE EXPRESSION REGULATION; GENE STRUCTURE; GROWTH DISORDER; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOTHESIS; LIFESPAN; MOLECULAR DYNAMICS; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SHORT STATURE; SIGNAL TRANSDUCTION; TISSUE REPAIR;

ANIMALS; CHILD; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEOPLASMS;

EID: 14644438558     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1602-1     Document Type: Review

References (109)

1. Salmon WD, Daughaday WH (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825-836 1:CAS:528:DyaG2sXhtVSms74%3D
2. Daughaday WH, Rotwein P (1989) Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-91 1:CAS:528:DyaL1MXhs1Khsrc%3D
3. Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3-34 10.1210/ er.16.1.3
4. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A (2001) The somatomedin hypothesis: 2001. Endocr Rev 22:53-74 10.1210/er.22.1.53
5. Melmed S (2001) In: DeGroot LJ, Jameson JL (eds) Saunders, Philadelphia, pp 300-312
6. Frank RN (2004) Diabetic retinopathy. N Engl J Med 350:48-58 10.1056/ NEJMra021678
7. Tatar M, Bartke A, Antebi A (2003) The endocrine regulation of aging by insulin-like signals. Science 299:1346-1351 10.1126/science.1081447
8. Ibrahim YH, Yee D (2004) Insulin-like growth factor-I and cancer risk. Growth Horm IGF Res (in press)
9. Laban C, Bustin SA, Jenkins PJ (2003) The GH-IGF-I axis and breast cancer. Trends Endocrinol Metab 14:28-34 10.1016/S1043-2760(02)00003-6
10. Mayo KE (1996) A little lesson in growth regulation. Nat Genet 12:8-9 10.1038/ng0196-8
11. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J (1994) Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 15:369-390 10.1210/er.15.3.369
12. Goddard AD, Covello R, Luoh SM, Clackson T, Attie KM, Gesundheit N, Rundle AC, Wells JA, Carlsson LM (1995) Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. N Engl J Med 333:1093-1098 10.1056/ NEJM199510263331701
13. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ, Chernausek SD (2003) IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349:2211-2222 10.1056/NEJMoa010107
14. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363-1367 10.1056/NEJM199610313351805
15. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA (1993) IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617 1:CAS:528:DyaK2cXntVajsw%3D%3D
16. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72 10.1016/ 0092-8674(93)90679-K
17. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A (2001) Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-162 10.1006/dbio.2000.9975
18. Sims NA, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA (2000) Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 106:1095-1103 1:CAS:528:DC%2BD3cXnvFyqtbk%3D
19. Miyakoshi N, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S (2001) Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology 142:4349-4356 10.1210/en.142.10.4349
20. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441 10.1056/NEJM200105103441904
21. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A (1997) Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961-2970 1:CAS:528:DyaK2sXktV2quro%3D
22. McCarthy TL, Centrella M, Canalis E (1989) Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 124:1247-1253 1:CAS:528:DyaL1MXht12js7s%3D
23. Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, Azuma Y, Ohta T, Kadowaki T, Nakamura K, Kawaguchi H (2000) Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 105:935-943 1:CAS:528:DC%2BD3cXit1yns74%3D
24. Fernandez AM, Dupont J, Farrar RP, Lee S, Stannard B, Le Roith D (2002) Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle. J Clin Invest 109:347-355 10.1172/ JCI200213503
25. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ (1995) Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270:12109-12116 10.1074/jbc.270.20.12109
26. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL (1998) Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 95:15603-15607 10.1073/pnas.95.26.15603
27. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014-1019 10.1038/ncb1101-1014
28. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N (2001) Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27:195-200
29. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL (2002) Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157:137-148 10.1083/jcb.200108071
30. Caroni P, Schneider C (1994) Signaling by insulin-like growth factors in paralyzed skeletal muscle: Rapid induction of IGF1 expression in muscle fibers and prevention of interstitial cell proliferation by IGF-BP5 and IGF-BP4. J Neurosci 14:3378-3388 1:CAS:528:DyaK2cXkt1Okt7g%3D
31. Edwall D, Schalling M, Jennische E, Norstedt G (1989) Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology 124:820-825 1:CAS:528:DyaL1MXhtV2jsL0%3D
32. DeVol DL, Rotwein P, Sadow JL, Novakofski J, Bechtel PJ (1990) Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am J Physiol 259:E89-E95 1:CAS:528:DyaK3cXlt1OisLg%3D
33. Carson JA, Nettleton D, Reecy JM (2002) Differential gene expression in the rat soleus muscle during early work overload-induced hypertrophy. FASEB J 16:207-209 1:CAS:528:DC%2BD38XhsVeqt7s%3D
34. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
35. Kaaks R, Lundin E, Rinaldi S, Manjer J, Biessy C, Soderberg S, Lenner P, Janzon L, Riboli E, Berglund G, Hallmans G (2002) Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13:307-316 10.1023/A:1015270324325
36. Missmer SA, Haiman CA, Hunter DJ, Willett WC, Colditz GA, Speizer FE, Pollak MN, Hankinson SE (2002) A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer 100:332-336 10.1002/ijc.10473
37. Ruan W, Kleinberg DL (1999) Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development Endocrinology 140 5075-5081 10.1210/en.140.11.5075
38. Hadsell DL, Greenberg NM, Fligger JM, Baumrucker CR, Rosen JM (1996) Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology 137:321-330 10.1210/en.137.1.321
39. Tornell J, Carlsson B, Pohjanen P, Wennbo H, Rymo L, Isaksson O (1992) High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice. J Steroid Biochem Mol Biol 43:237-242 10.1016/ 0960-0760(92)90213-3
40. Bates P, Fisher R, Ward A, Richardson L, Hill DJ, Graham CF (1995) Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 72:1189-1193 1:CAS:528:DyaK28XktVyrug%3D%3D
41. Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FCJ, Allred DC, Osborne CK (1989) Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418-1423 1:CAS:528:DyaL1MXmt1Kjs78%3D
42. Yang XF, Beamer WG, Huynh H, Pollak M (1996) Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation. Cancer Res 56:1509-1511 1:CAS:528:DyaK28XitVemsLo%3D
43. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 279:563-566 10.1126/ science.279.5350.563
44. Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R (2000) Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study. J Natl Cancer Inst 92:1910-1917 10.1093/jnci/92.23.1910
45. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625 10.1093/jnci/91.7.620
46. Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, Riboli E, Kaaks R (2002) Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: A prospective study in northern Sweden. Gut 50:642-646 10.1136/gut.50.5.642
47. Kenyon C (2001) A conserved regulatory system for aging. Cell 105:165-168 10.1016/S0092-8674(01)00306-3
48. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, Ruvkun G (1997) The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389:994-999 10.1038/40194
49. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G (1997) daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277 942-946 10.1126/science.277.5328.942
50. Lin K, Dorman JB, Rodan A, Kenyon C (1997) daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278:1319-1322 10.1126/ science.278.5341.1319
51. Apfeld J, Kenyon C (1998) Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and life span. Cell 95:199-210 10.1016/ S0092-8674(00)81751-1
52. Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, Garofalo RS (2001) A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292 107-110 10.1126/ science.1057987
53. Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E, Leevers SJ, Partridge L (2001) Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292:104-106 10.1126/science.1057991
54. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A (1996) Dwarf mice and the ageing process. Nature 384:33 10.1038/384033a0
55. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE (2001) Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA 98:6736-6741 10.1073/pnas.111158898
56. Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ (2000) Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141:2608-2613 10.1210/en.141.7.2608
57. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, Le Bouc Y (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421:182-187 10.1038/nature01298
58. Herrington J, Carter-Su C (2001) Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab 12:252-257 10.1016/ S1043-2760(01)00423-4
59. Ridderstrale M, Degerman E, Tornqvist H (1995) Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J Biol Chem 270:3471-3474 10.1074/jbc.270.8.3471
60. Argetsinger LS, Norstedt G, Billestrup N, White MF, Carter-Su C (1996) Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J Biol Chem 271:29415-29421 10.1074/jbc.271.46.29415
61. Argetsinger LS, Hsu GW, Myers MGJ, Billestrup N, White MF, Carter-Su C (1995) Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J Biol Chem 270:14685-14692 10.1074/jbc.270.24.14685
62. Vanderkuur JA, Butch ER, Waters SB, Pessin JE, Guan KL, Carter-Su C (1997) Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation. Endocrinology 138:4301-4307 10.1210/en.138.10.4301
63. VanderKuur J, Allevato G, Billestrup N, Norstedt G, Carter-Su C (1995) Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J Biol Chem 270:7587-7593 10.1074/jbc.270.13.7587
64. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahashi M, Takahashi T, Hirai H, Tushima T, Akanuma Y, Fujita T, Komuro I, Yazaki Y, Kadowaki T (1997) Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390:91-96 10.1038/36369
65. Chow JC, Ling PR, Qu Z, Laviola L, Ciccarone A, Bistrian BR, Smith RJ (1996) Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology 137:2880-2886 10.1210/en.137.7.2880
66. Love DW, Whatmore AJ, Clayton PE, Silva CM (1998) Growth hormone stimulation of the mitogen-activated protein kinase pathway is cell type specific. Endocrinology 139:1965-1971 10.1210/en.139.4.1965
67. Rui L, Mathews LS, Hotta K, Gustafson TA, Carter-Su C (1997) Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol Cell Biol 17:6633-6644 1:CAS:528:DyaK2sXntVSqsbk%3D
68. Ram PA, Waxman DJ (1997) Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J Biol Chem 272:17694-17702 10.1074/jbc.272.28.17694
69. Kim SO, Jiang J, Yi W, Feng GS, Frank SJ (1998) Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling. J Biol Chem 273:2344-2354 10.1074/jbc.273.4.2344
70. Stofega MR, Wang H, Ullrich A, Carter-Su C (1998) Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association. J Biol Chem 273:7112-7117 10.1074/jbc.273.12.7112
71. Zhu T, Goh EL, Lobie PE (1998) Growth hormone stimulates the tyrosine phosphorylation and association of p125 focal adhesion kinase (FAK) with JAK2. Fak is not required for stat-mediated transcription. J Biol Chem 273:10682-10689 10.1074/jbc.273.17.10682
72. Adams TE, Hansen JA, Starr R, Nicola NA, Hilton DJ, Billestrup N (1998) Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J Biol Chem 273:1285-1287 10.1074/jbc.273.3.1285
73. Greenhalgh CJ, Bertolino P, Asa SL, Metcalf D, Corbin JE, Adams TE, Davey HW, Nicola NA, Hilton DJ, Alexander WS (2002) Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol Endocrinol 16:1394-1406 10.1210/me.16.6.1394
74. Levy DE Darnell JEJ (2002) Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651-662
75. Gronowski AM, Rotwein P (1994) Rapid changes in nuclear protein tyrosine phosphorylation after growth hormone treatment in vivo. Identification of phosphorylated mitogen-activated protein kinase and STAT91. J Biol Chem 269:7874-7878 1:CAS:528:DyaK2cXitlKmtLc%3D
76. Gronowski AM, Zhong Z, Wen Z, Thomas MJ, Darnell JEJ, Rotwein P (1995) In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3. Mol Endocrinol 9:171-177 10.1210/me.9.2.171
77. Ram PA, Park SH, Choi HK, Waxman DJ (1996) Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J Biol Chem 271:5929-5940 10.1074/jbc.271.10.5929
78. Campbell GS, Meyer DJ, Raz R, Levy DE, Schwartz J, Carter-Su C (1995) Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. J Biol Chem 270:3974-3979 10.1074/ jbc.270.8.3974
79. Smit LS, Vanderkuur JA, Stimage A, Han Y, Luo G, Yu-Lee LY, Schwartz J, Carter-Su C (1997) Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B. Endocrinology 138:3426-3434 10.1210/en.138.8.3426
80. Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J, Carter-Su C (1996) The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol Endocrinol 10:519-533 10.1210/me.10.5.519
81. Gebert CA, Park SH, Waxman DJ (1997) Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation. Mol Endocrinol 11:400-414 10.1210/ me.11.4.400
82. Yoon JB, Berry SA, Seelig S, Towle HC (1990) An inducible nuclear factor binds to a growth hormone-regulated gene. J Biol Chem 265:19947-19954 1:CAS:528:DyaK3cXlvVGrtrg%3D
83. Berry SA, Bergad PL, Whaley CD, Towle HC (1994) Binding of a growth hormone-inducible nuclear factor is mediated by tyrosine phosphorylation. Mol Endocrinol 8:1714-1719 10.1210/me.8.12.1714
84. Bergad PL, Shih HM, Towle HC, Schwarzenberg SJ, Berry SA (1995) Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites. J Biol Chem 270:24903-24910 10.1074/ jbc.270.42.24903
85. Teglund S, McKay C, Schuetz E, Deursen JM van, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841-850 10.1016/S0092-8674(00)81444-0
86. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94:7239-7244 10.1073/pnas.94.14.7239
87. Pfitzner E, Jahne R, Wissler M, Stoecklin E, Groner B (1998) p300/ CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol Endocrinol 12:1582-1593 10.1210/ me.12.10.1582
88. Ye SK, Agata Y, Lee HC, Kurooka H, Kitamura T, Shimizu A, Honjo T, Ikuta K (2001) The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and histone acetylation. Immunity 15:813-823 10.1016/ S1074-7613(01)00230-8
89. Peng B, Sutherland KD, Sum EY, Olayioye M, Wittlin S, Tang TK, Lindeman GJ, Visvader JE (2002) CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity. Mol Endocrinol 16:2019-2033 10.1210/me.2002-0108
90. Rascle A, Johnston JA, Amati B (2003) Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5. Mol Cell Biol 23:4162-4173 10.1128/MCB.23.12.4162-4173.2003
91. Xu M, Nie L, Kim SH, Sun XH (2003) STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta. EMBO J 22:893-904 10.1093/emboj/cdg094
92. Rotwein P (1999) In: Rosenfeld R, Roberts CJ (eds) Molecular biology of IGF-I and IGF-II. Humana, Totowa, N.J., pp 19-35
93. Kajimoto Y, Rotwein P (1991) Structure of the chicken insulin-like growth factor I gene reveals conserved promoter elements. J Biol Chem 266:9724-9731 1:CAS:528:DyaK3MXksVeiurY%3D
94. Kavsan VM, Koval AP, Grebenjuk VA, Chan SJ, Steiner DF, Roberts CTJ, LeRoith D (1993) Structure of the chum salmon insulin-like growth factor I gene. DNA Cell Biol 12:729-737 1:CAS:528:DyaK2cXntVGhtA%3D%3D
95. Hall LJ, Kajimoto Y, Bichell D, Kim SW, James PL, Counts D, Nixon LJ, Tobin G, Rotwein P (1992) Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter. DNA Cell Biol 11:301-313 1:CAS:528:DyaK38Xks1Cjtb0%3D
96. Adamo ML, Ben-Hur H, Roberts CTJ, LeRoith D (1991) Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes. Mol Endocrinol 5:1677-1686 1:CAS:528:DyaK38Xhs1aksQ%3D%3D
97. Shimatsu A, Rotwein P (1987) Mosaic evolution of the insulin-like growth factors. Organization, sequence, and expression of the rat insulin-like growth factor I gene. J Biol Chem 262:7894-7900 1:CAS:528:DyaL2sXlvFajsLg%3D
98. Kim SW, Lajara R, Rotwein P (1991) Structure and function of a human insulin-like growth factor-I gene promoter. Mol Endocrinol 5:1964-1972 1:CAS:528:DyaK38Xit12ntLs%3D
99. Hoyt EC, Van Wyk JJ, Lund PK (1988) Tissue and development specific regulation of a complex family of rat insulin-like growth factor I messenger ribonucleic acids. Mol Endocrinol 2:1077-1086 1:CAS:528:DyaL1MXntVantA%3D%3D
100. Woelfle J, Billiard J, Rotwein P (2003) Acute control of insulin-like growth factor-1 gene transcription by growth hormone through STAT5B. J Biol Chem 278:22696-22702 10.1074/jbc.M301362200
101. Woelfle J, Chia DJ, Rotwein P (2003) Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. J Biol Chem 278:51261-51266 10.1074/jbc.M309486200
102. Bichell DP, Kikuchi K, Rotwein P (1992) Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo. Mol Endocrinol 6:1899-1908 10.1210/me.6.11.1899
103. An MR, Lowe WLJ (1995) The major promoter of the rat insulin-like growth factor-I gene binds a protein complex that is required for basal expression. Mol Cell Endocrinol 114:77-89 10.1016/0303-7207(95)03644-M
104. Mittanck DW, Kim SW, Rotwein P (1997) Essential promoter elements are located within the 5′ untranslated region of human insulin-like growth factor-I exon I. Mol Cell Endocrinol 126:153-163 10.1016/ S0303-7207(96)03979-2
105. Wang L, Wang X, Adamo ML (2000) Two putative GATA motifs in the proximal exon 1 promoter of the rat insulin-like growth factor I gene regulate basal promoter activity. Endocrinology 141:1118-1126 10.1210/ en.141.3.1118
106. Wang X, Talamantez JL, Adamo ML (1998) A CACCC box in the proximal exon 2 promoter of the rat insulin-like growth factor I gene is required for basal promoter activity. Endocrinology 139:1054-1066 10.1210/ en.139.3.1054
107. Thomas MJ, Kikuchi K, Bichell DP, Rotwein P (1995) Characterization of deoxyribonucleic acid-protein interactions at a growth hormone-inducible nuclease hypersensitive site in the rat insulin-like growth factor-I gene. Endocrinology 136:562-569 10.1210/en.136.2.562
108. Ye P, Umayahara Y, Ritter D, Bunting T, Auman H, Rotwein P, D'Ercole AJ (1997) Regulation of insulin-like growth factor I (IGF-I) gene expression in brain of transgenic mice expressing an IGF-I-luciferase fusion gene. Endocrinology 138:5466-5475 10.1210/en.138.12.5466
109. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG (2003). Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 349:1139-1147 10.1056/NEJMoa022926